<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40829371</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>102076</StartPage><MedlinePgn>102076</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2025.102076</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2772-963X(25)00501-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Disparities in cardiovascular disease presentation and outcomes between men and women are well-documented. While intravascular imaging (IVI) improves percutaneous coronary intervention (PCI) outcomes, its potential sex-specific benefits remain unclear.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to determine sex differences in adverse cardiovascular events in coronary artery disease patients undergoing PCI with IVI guidance vs angiography alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic review of PubMed, Scopus, and Cochrane databases was conducted to identify randomized controlled trials comparing major adverse cardiovascular events (MACE) in men and women with coronary artery disease (presenting with acute or chronic coronary syndrome) undergoing IVI-guided vs angiography-guided PCI. Risk ratios (RRs) with 95% CIs were calculated using random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight randomized controlled trials, comprising 14,812 patients (76.1% men and 23.9% women) were included. IVI-guided PCI significantly reduced MACE in both men (RR: 0.69; 95% CI: 0.58-0.81; P &lt; 0.001) and women (RR: 0.64; 95% CI: 0.49-0.82; P &lt; 0.001) compared with angiography alone (P<sub>interaction</sub> = 0.62). Intravascular ultrasound-guided PCI reduced MACE in men and women compared with angiography alone (P<sub>interaction</sub> = 0.86). Optical coherence tomography-guided PCI reduced MACE in men but not in women compared with angiography alone (P<sub>interaction</sub> = 0.86).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite the underrepresentation of women in IVI-guided PCI trials, this meta-analysis demonstrates that IVI-guided PCI confers a comparable reduction in MACE for both men and women, suggesting its potential to mitigate the long-standing sex-specific disparities in coronary intervention outcomes and supports its broader implementation in clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ezenna</LastName><ForeName>Chidubem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Massachusetts - Baystate Medical Center, Springfield, Massachusetts, USA. Electronic address: Cezenna349@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Sammudeen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramesh</LastName><ForeName>Prasana</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Massachusetts - Baystate Medical Center, Springfield, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismayl</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>Mrinal Murali</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Medical College Thiruvananthapuram, Trivandrum, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Meghna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Medical College Thiruvananthapuram, Trivandrum, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Kuan-Yu</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altin</LastName><ForeName>S Elissa</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanna</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldsweig</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Baystate Medical Center and Division of Cardiovascular Medicine, University of Massachusetts-Baystate, Springfield, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular outcomes</Keyword><Keyword MajorTopicYN="N">intravascular imaging</Keyword><Keyword MajorTopicYN="N">intravascular ultrasound</Keyword><Keyword MajorTopicYN="N">optical coherence tomography</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword></KeywordList><CoiStatement>Funding support and author disclosures Dr Goldsweig has consulted for Philips, Inari Medical, and Conformal Medical; and has done speaking for Philips and Edwards Lifesciences. Dr Nanna has received unrelated current research support from the American College of Cardiology Foundation supported by the George F. and Ann Harris Bellows Foundation, the Patient-Centered Outcomes Research Institute (PCORI), the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342), and the National Institute on Aging (K76AG088428)&#x2014;personal fees from Heartflow, Inc, Merck, and Novo Nordisk. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>19</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40829371</ArticleId><ArticleId IdType="pmc">PMC12391688</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2025.102076</ArticleId><ArticleId IdType="pii">S2772-963X(25)00501-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dalen J.E., Alpert J.S., Goldberg R.J., Weinstein R.S. The epidemic of the 20th century: coronary heart disease. Am J Med. 2014;127:807&#x2013;812. doi: 10.1016/j.amjmed.2014.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2014.04.015</ArticleId><ArticleId IdType="pubmed">24811552</ArticleId></ArticleIdList></Reference><Reference><Citation>Truesdell A.G., Alasnag M.A., Kaul P., et al. Intravascular imaging during percutaneous coronary intervention: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81:590&#x2013;605. doi: 10.1016/j.jacc.2022.11.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.11.045</ArticleId><ArticleId IdType="pubmed">36754518</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone G.W., Christiansen E.H., Ali Z.A., et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet. 2024;403:824&#x2013;837. doi: 10.1016/S0140-6736(23)02454-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)02454-6</ArticleId><ArticleId IdType="pubmed">38401549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezenna C., Krishna M.M., Joseph M., et al. Optical coherence tomography vs. Angiography alone to guide PCI for complex lesions: a meta-analysis of randomized controlled trials. Circ Cardiovasc Interv. 2025;18 doi: 10.1161/CIRCINTERVENTIONS.125.015141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.125.015141</ArticleId><ArticleId IdType="pubmed">40159113</ArticleId></ArticleIdList></Reference><Reference><Citation>Chichareon P., Modolo R., Kerkmeijer L., et al. Association of sex with outcomes in patients undergoing percutaneous coronary intervention: a subgroup analysis of the global leaders randomized clinical trial. JAMA Cardiol. 2020;5:21&#x2013;29. doi: 10.1001/jamacardio.2019.4296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.4296</ArticleId><ArticleId IdType="pmc">PMC7029729</ArticleId><ArticleId IdType="pubmed">31693078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochman J.S., Tamis J.E., Thompson T.D., et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med. 1999;341:226&#x2013;232. doi: 10.1056/NEJM199907223410402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199907223410402</ArticleId><ArticleId IdType="pubmed">10413734</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S.N., Mamas M.A. Narrowing disparities in PCI outcomes in women; from risk assessment, to referral pathways and outcomes. Am Heart J Plus. 2022;24 doi: 10.1016/j.ahjo.2022.100225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2022.100225</ArticleId><ArticleId IdType="pmc">PMC10978432</ArticleId><ArticleId IdType="pubmed">38560635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmidou I., Leon M.B., Zhang Y., et al. Long-Term outcomes in women and men following percutaneous coronary intervention. J Am Coll Cardiol. 2020;75:1631&#x2013;1640. doi: 10.1016/j.jacc.2020.01.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.01.056</ArticleId><ArticleId IdType="pubmed">32273029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.V., O&#x2019;Donoghue M.L., Ruel M., et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2025;151:e771&#x2013;e862. doi: 10.1161/CIR.0000000000001309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001309</ArticleId><ArticleId IdType="pubmed">40014670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian N.L., Gami S.K., Ye F., et al. Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015;10:1409&#x2013;1417. doi: 10.4244/eijv10i12a245.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/eijv10i12a245</ArticleId><ArticleId IdType="pubmed">25912391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.-K., Shin D.-H., Hong M.-K., et al. Clinical impact of intravascular ultrasound&#x2013;guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation. Circ Cardiovasc Interv. 2015;8 doi: 10.1161/CIRCINTERVENTIONS.115.002592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.115.002592</ArticleId><ArticleId IdType="pubmed">26156151</ArticleId></ArticleIdList></Reference><Reference><Citation>Meneveau N., Souteyrand G., Motreff P., et al. Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non&#x2013;ST-elevation acute coronary syndrome. Circulation. 2016;134:906&#x2013;917. doi: 10.1161/CIRCULATIONAHA.116.024393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.024393</ArticleId><ArticleId IdType="pubmed">27573032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismayl M., Ahmed H., Goldsweig A.M., et al. Racial/ethnic, sex, and economic disparities in the utilization and outcomes of intracoronary imaging. J Soc Cardiovasc Angiogr Interv. 2024;3 doi: 10.1016/j.jscai.2024.101936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2024.101936</ArticleId><ArticleId IdType="pmc">PMC11308510</ArticleId><ArticleId IdType="pubmed">39132585</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L., Moher D., Clarke M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349 doi: 10.1136/bmj.g7647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis S.G., Vandormael M.G., Cowley M.J., et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193&#x2013;1202. doi: 10.1161/01.CIR.82.4.1193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.82.4.1193</ArticleId><ArticleId IdType="pubmed">2401060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">19758907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A.C., Savovi&#x107; J., Page M.J., et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366 doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo B.-K., Hu X., Kang J., et al. Fractional flow reserve or intravascular ultrasonography to guide PCI. N Engl J Med. 2022;387:779&#x2013;789. doi: 10.1056/NEJMoa2201546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2201546</ArticleId><ArticleId IdType="pubmed">36053504</ArticleId></ArticleIdList></Reference><Reference><Citation>Burzotta F., Zito A., Aurigemma C., et al. Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial. EHJ. 2024;45:2785&#x2013;2788. doi: 10.1093/eurheartj/ehae290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae290</ArticleId><ArticleId IdType="pmc">PMC11313556</ArticleId><ArticleId IdType="pubmed">38848104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S.-J., Mintz G.S., Ahn C.-M., et al. Effect of intravascular ultrasound&#x2013;guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial. JACC Cardiovasc Interv. 2020;13:62&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">31918944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X.-F., Ge Z., Kong X.-Q., et al. 3-Year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation. JACC Cardiovasc Interv. 2021;14:247&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">33541535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.M., Choi K.H., Song Y.B., et al. Intravascular imaging&#x2013;guided or angiography-guided complex PCI. N Engl J Med. 2023;388:1668&#x2013;1679. doi: 10.1056/NEJMoa2216607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2216607</ArticleId><ArticleId IdType="pubmed">36876735</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm N.R., Andreasen L.N., Neghabat O., et al. OCT or angiography guidance for PCI in complex bifurcation lesions. N Engl J Med. 2023;389:1477&#x2013;1487. doi: 10.1056/NEJMoa2307770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2307770</ArticleId><ArticleId IdType="pubmed">37634149</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali Z.A., Landmesser U., Maehara A., et al. Optical coherence tomography&#x2013;guided versus angiography-guided PCI. N Engl J Med. 2023;389:1466&#x2013;1476. doi: 10.1056/NEJMoa2305861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2305861</ArticleId><ArticleId IdType="pubmed">37634188</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Ge Z., Kan J., et al. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet. 2024;403:1855&#x2013;1865. doi: 10.1016/S0140-6736(24)00282-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)00282-4</ArticleId><ArticleId IdType="pubmed">38604212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S.-J., Lee S.-J., Lee S.-H., et al. Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea. Lancet. 2024;404:1029&#x2013;1039. doi: 10.1016/S0140-6736(24)01454-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01454-5</ArticleId><ArticleId IdType="pubmed">39236729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.H., Hong S.J., Kim H.-S., et al. Quantitative coronary angiography vs intravascular ultrasonography to guide drug-eluting stent implantation: a randomized clinical trial. JAMA Cardiol. 2024;9:428&#x2013;435. doi: 10.1001/jamacardio.2024.0059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2024.0059</ArticleId><ArticleId IdType="pmc">PMC10938248</ArticleId><ArticleId IdType="pubmed">38477913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakab&#x10d;in J., &#x160;pa&#x10d;ek R., Bystro&#x148; M., et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Cathet Cardio Intervent. 2010;75:578&#x2013;583. doi: 10.1002/ccd.22244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.22244</ArticleId><ArticleId IdType="pubmed">19902491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chieffo A., Latib A., Caussin C., et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2013;165:65&#x2013;72. doi: 10.1016/j.ahj.2012.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2012.09.017</ArticleId><ArticleId IdType="pubmed">23237135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-S., Kang T.-S., Mintz G.S., et al. Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses. JACC Cardiovasc Interv. 2013;6:369&#x2013;376. doi: 10.1016/j.jcin.2012.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2012.11.009</ArticleId><ArticleId IdType="pubmed">23523455</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonsen L., Thayssen P., Maehara A., et al. Optical coherence tomography guided percutaneous coronary intervention with nobori stent implantation in patients with non&#x2013;ST-segment&#x2013;elevation myocardial infarction (OCTACS) trial. Circ Cardiovasc Interv. 2015;8 doi: 10.1161/CIRCINTERVENTIONS.114.002446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.114.002446</ArticleId><ArticleId IdType="pubmed">26253735</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q., Wang Q., Liu D., et al. Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly. Saudi Med J. 2015;36:549&#x2013;553. doi: 10.15537/smj.2015.5.11251.</Citation><ArticleIdList><ArticleId IdType="doi">10.15537/smj.2015.5.11251</ArticleId><ArticleId IdType="pmc">PMC4436750</ArticleId><ArticleId IdType="pubmed">25935174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-S., Shin D.-H., Kim B.-K., et al. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed) 2015;68:190&#x2013;197. doi: 10.1016/j.rec.2014.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2014.07.025</ArticleId><ArticleId IdType="pubmed">25487222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kala P., Cervinka P., Jakl M., et al. OCT guidance during stent implantation in primary PCI: a randomized multicenter study with nine months of optical coherence tomography follow-up. Int J Cardiol. 2018;250:98&#x2013;103. doi: 10.1016/j.ijcard.2017.10.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.10.059</ArticleId><ArticleId IdType="pubmed">29079414</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.M., Yang Z.M., Liu X.K., et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: a single-center randomized trial. Anatol J Cardiol. 2019;21:83&#x2013;90. doi: 10.14744/AnatolJCardiol.2018.21447.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/AnatolJCardiol.2018.21447</ArticleId><ArticleId IdType="pmc">PMC6457420</ArticleId><ArticleId IdType="pubmed">30694800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali Z.A., Karimi Galougahi K., Maehara A., et al. Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial. EuroIntervention. 2021;16:1085&#x2013;1091. doi: 10.4244/eij-d-20-00498.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/eij-d-20-00498</ArticleId><ArticleId IdType="pmc">PMC9724851</ArticleId><ArticleId IdType="pubmed">32540793</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H., Dai J., He L., et al. Erosion III: a multicenter RCT of OCT-guided reperfusion in STEMI with early infarct artery patency. JACC Cardiovasc Interv. 2022;15:846&#x2013;856. doi: 10.1016/j.jcin.2022.01.298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2022.01.298</ArticleId><ArticleId IdType="pubmed">35367176</ArticleId></ArticleIdList></Reference><Reference><Citation>Chami&#xe9; D., Costa J.R., Jr., Damiani L.P., et al. Optical coherence tomography versus intravascular ultrasound and angiography to guide percutaneous coronary interventions: the iSIGHT randomized trial. Circ Cardiovasc Interv. 2021;14(3) doi: 10.1161/CIRCINTERVENTIONS.120.009452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.120.009452</ArticleId><ArticleId IdType="pubmed">33685212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirillo P., Di Serafino L., Patti G., et al. Gender-related differences in antiplatelet therapy and impact on 1-year clinical outcome in patients presenting with ACS: the START ANTIPLATELET registry. Angiology. 2019;70(3):257&#x2013;263. doi: 10.1177/0003319718783866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003319718783866</ArticleId><ArticleId IdType="pubmed">29969919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta L.S., Beckie T.M., DeVon H.A., et al. Acute myocardial infarction in women. Circulation. 2016;133:916&#x2013;947. doi: 10.1161/CIR.0000000000000351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000351</ArticleId><ArticleId IdType="pubmed">26811316</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan J.J., R&#xe4;ber L., Brugaletta S., et al. Sex differences in 10-year outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation. Circulation. 2023;147:575&#x2013;585. doi: 10.1161/CIRCULATIONAHA.122.062049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062049</ArticleId><ArticleId IdType="pubmed">36780380</ArticleId></ArticleIdList></Reference><Reference><Citation>Udell J.A., Koh M., Qiu F., et al. Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization. J Am Heart Assoc. 2017;6 doi: 10.1161/JAHA.116.004319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004319</ArticleId><ArticleId IdType="pmc">PMC5523628</ArticleId><ArticleId IdType="pubmed">28108465</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S., Stouffer G.A., Kucharska-Newton A.M., et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139:1047&#x2013;1056. doi: 10.1161/CIRCULATIONAHA.118.037137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.037137</ArticleId><ArticleId IdType="pmc">PMC6380926</ArticleId><ArticleId IdType="pubmed">30586725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambola A., Del Blanco B.G., Kunadian V., et al. Sex-based differences in percutaneous coronary intervention outcomes in patients with ischaemic heart disease. Eur Cardiol. 2023;18:e06. doi: 10.15420/ecr.2022.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2022.24</ArticleId><ArticleId IdType="pmc">PMC10345982</ArticleId><ArticleId IdType="pubmed">37456769</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha J.H., Lee J.M., Choi K.H., et al. Intravascular imaging&#x2013;guided optimization of complex percutaneous coronary intervention by sex: a subgroup analysis of the RENOVATE-COMPLEX-PCI trial. JAMA Cardiol. 2024;9:466&#x2013;474. doi: 10.1001/jamacardio.2024.0291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2024.0291</ArticleId><ArticleId IdType="pmc">PMC10993152</ArticleId><ArticleId IdType="pubmed">38568686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.-Y., Ahn J.-M., Yun S.-C., et al. Optical coherence tomography&#x2013;guided or intravascular ultrasound&#x2013;guided percutaneous coronary intervention: the OCTIVUS randomized clinical trial. Circulation. 2023;148:1195&#x2013;1206. doi: 10.1161/CIRCULATIONAHA.123.066429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.066429</ArticleId><ArticleId IdType="pubmed">37634092</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeglin-Sawczuk M., Jang I.K., Kato K., et al. Lipid rich plaque, female gender and proximal coronary stent edge dissections. J Thromb Thrombolysis. 2013;36(4):507&#x2013;513. doi: 10.1007/s11239-013-0882-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-013-0882-3</ArticleId><ArticleId IdType="pubmed">23378150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekhar J., Mehran R. Sex-based differences in acute coronary syndromes: insights from invasive and noninvasive coronary technologies. JACC Cardiovasc Imaging. 2016;9:451&#x2013;464. doi: 10.1016/j.jcmg.2016.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2016.02.004</ArticleId><ArticleId IdType="pubmed">27056164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Jiang J., Hu X., et al. Sex differences in fractional flow reserve&#x2013; or intravascular ultrasound&#x2013;guided percutaneous coronary intervention. JACC Cardiovasc Imaging. 2023;16:2426&#x2013;2435. doi: 10.1016/j.jcin.2023.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2023.08.017</ArticleId><ArticleId IdType="pubmed">37638768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera F.B., Tang V.A.S., De Luna D.V., et al. Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: a systematic review and meta-analysis. Am Heart J Plus. 2023;26 doi: 10.1016/j.ahjo.2023.100261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2023.100261</ArticleId><ArticleId IdType="pmc">PMC10256233</ArticleId><ArticleId IdType="pubmed">37305172</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunstein J.B., Sherber N.S., Schulman S.P., et al. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine. 2008;87:1&#x2013;9. doi: 10.1097/MD.0b013e3181625d78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0b013e3181625d78</ArticleId><ArticleId IdType="pubmed">18204365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mather M., Lighthall N.R. Risk and reward are processed differently in decisions made under stress. Curr Dir Psychol Sci. 2012;21:36&#x2013;41. doi: 10.1177/0963721411429452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963721411429452</ArticleId><ArticleId IdType="pmc">PMC3312579</ArticleId><ArticleId IdType="pubmed">22457564</ArticleId></ArticleIdList></Reference><Reference><Citation>Michos E.D., Reddy T.K., Gulati M., et al. Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: an ASPC practice statement. Am J Prev Cardiol. 2021;8 doi: 10.1016/j.ajpc.2021.100250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpc.2021.100250</ArticleId><ArticleId IdType="pmc">PMC8408620</ArticleId><ArticleId IdType="pubmed">34485967</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott P.E., Unger E.F., Jenkins M.R., et al. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. J Am Coll Cardiol. 2018;71:1960&#x2013;1969. doi: 10.1016/j.jacc.2018.02.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.02.070</ArticleId><ArticleId IdType="pubmed">29724348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding E.L., Powe N.R., Manson J.E., et al. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Arch Intern Med. 2007;167:905&#x2013;912. doi: 10.1001/archinte.167.9.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.9.905</ArticleId><ArticleId IdType="pubmed">17502531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Jones D.M., Larson M.G., Beiser A., Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89&#x2013;92. doi: 10.1016/s0140-6736(98)10279-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(98)10279-9</ArticleId><ArticleId IdType="pubmed">10023892</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S.A.E., Woodward M. A roadmap for sex- and gender-disaggregated health research. BMC Med. 2023;21:354. doi: 10.1186/s12916-023-03060-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03060-w</ArticleId><ArticleId IdType="pmc">PMC10500779</ArticleId><ArticleId IdType="pubmed">37704983</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Chandramouli C., Allocco B., et al. Women&#x2019;s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141:540&#x2013;548. doi: 10.1161/CIRCULATIONAHA.119.043594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043594</ArticleId><ArticleId IdType="pubmed">32065763</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>